A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy.
Satta A, Grazia G, Caroli F, Frigerio B, Di Nicola M, Raspagliesi F, Mezzanzanica D, Zaffaroni N, Gianni AM, Anichini A, Figini M.
Satta A, et al. Among authors: frigerio b.
Front Immunol. 2019 Oct 25;10:2514. doi: 10.3389/fimmu.2019.02514. eCollection 2019.
Front Immunol. 2019.
PMID: 31708930
Free PMC article.